LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN: Who Reports Side Effects? Age, Gender & Country Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Gender Distribution
0.7%
Female
99.3%
Male
Age Information
The average age of patients reporting adverse events with LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN is 72.9 years.
Geographic Distribution
The majority of adverse event reports for LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN originate from US.
Report Summary & Outcomes
10,716
Total Reports
10,716
As Primary/Secondary Suspect
1,461
Deaths Reported
545
Hospitalizations
61
Life-Threatening
34
Disabilities
Reporting Timeline
First adverse event report: 20130101. Most recent report: 20250915. View full timeline →